Physicians aren’t sure how to treat the growing number of patients who take opioids laced with xylazine, an animal tranquilizer, because of its slim number of withdrawal treatments, The Philadelphia Inquirer reported Jan. 17.
Read the full post on Becker's Hospital Review - Healthcare News
